cardioscore.it

What It Is

Allelica is not a general-purpose enterprise collaboration SaaS product, but a genetic risk assessment and bioinformatics platform for precision medicine. Its core offering is multi-ancestry Polygenic Risk Score (PRS), designed to complement traditional tools such as LDL-C, family history, monogenic testing, and PSA. It helps physicians identify people whose routine indicators may appear normal but who have elevated genetic risk. The website focuses primarily on coronary artery disease, breast cancer risk assessment, and population stratification for pharmaceutical clinical trials.

Core Capabilities and Integrations

The platform emphasizes genetic ancestry analysis first, rather than relying solely on self-reported ethnicity. It builds PRS models by disease and ancestry using anywhere from thousands to millions of genome-wide variants. Its breast cancer solution, Breast Risk Reveal, combines monogenic mutations, polygenic risk scores, and clinical models such as Tyrer-Cuzick and BOADICEA. For laboratories, Allelica offers customizable panels, multilingual white-label reports, and claims it can fit into existing workflows. On the third-party side, the text explicitly states that its PRS software and reports are compatible with Thermo Fisher Scientific’s Axiom human genotyping arrays, and that it has a clinical implementation partnership with Baylor College of Medicine.

Pricing, Deployment, and Compliance

The website does not disclose plans, pricing, payment methods, or free trial information, so it appears to be oriented more toward B2B procurement by healthcare institutions via quotation. Deployment is one of its strengths: it supports both cloud deployment and on-premises deployment when data cannot leave an organization. Allelica Precision Server is used for local PRS, pharmacogenomics, carrier screening analysis, and clinical reporting. On compliance, the text lists CLIA registration number 22D2315916 and mentions CLIA Certification, ISO 13485, and ISO 9001, which are useful references for medical laboratory procurement.

Pros, Cons, and Best Fit

Its strengths are a clear product focus, multiple research and clinical use cases, and multi-ancestry calibration that may reduce the bias risks associated with traditional PRS across different populations. It also serves multiple stakeholders: physician decision-making, laboratory analysis and reporting, and pharmaceutical trial stratification. The downside is the lack of common enterprise software information: there are no clear details on team permissions, audit logs, APIs, developer documentation, SLAs, or support tiers, and pricing is not transparent. It is better suited to cardiovascular, oncology, and genetic counseling clinics, clinical laboratories, and pharmaceutical R&D teams, rather than general corporate wellness programs or direct self-service use by individuals.

Access from China and Alternatives

The website does not provide information on access, payment, or regulatory implementation for mainland China. Actual use may be affected by cross-border medical data rules, sample testing requirements, and network access, so each item should be verified individually. Chinese users considering clinical use should first confirm local regulatory requirements, data export rules, and laboratory qualification requirements. Comparable options include Myriad Genetics, Ambry Genetics, Color Health, Invitae, Illumina-related platforms, as well as compliant domestic providers with genetic testing and medical reporting capabilities.